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Abstract
PURPOSE: The purpose of this Doctor of Nursing Practice (DNP) project was to implement
depression screening with the Patient Health Questionnaire-9 (PHQ-9) among patients with
Coronary Heart Disease (CHD) who have undergone a Coronary Artery Bypass Graft (CABG)
and demonstrate the feasibility of a nurse-led Cognitive Behavioral Therapy (CBT) intervention.
METHODS: A non-experimental pre-test and post-test design was completed to screen for
depression among patients post CABG in the Cardiovascular Intensive Care Unit (CVICU) at a
University Hospital using the PHQ-9. A sample of 21 patients were identified and selected from
a convenience sample by pulling every eligible record from Institutional Review Board (IRB)
approval date. An evidence-based non-pharmacological (CBT) intervention for depressive
symptoms was provided to patients with a PHQ-9 score of 5 or greater. Patients who received the
CBT intervention were re-evaluated for depressive symptoms with the PHQ-9 at two weeks postsurgery. Follow-up care or referral was offered by the provider as appropriate if the patient
continued to screen positive for depression after CBT intervention.
RESULTS: A total of 38% (8 out of 21) screened positive for depression. Of 8 patients total that
screened positive for depression, 62.5% (5 out of 8) were re-screened post CBT-intervention
from which 60% (N = 3) had lower PHQ-9 scores indicating reduced depressive symptoms.
There was 1 patient death, 1 patient decline and 1 patient lost to follow-up. The paired t-test
analysis examining the difference in PHQ-9 scores at pre- and post-CBT was not significant;
however, this feasibility project was not powered to detect pre- and post-CBT differences in
depression scores. Related to limited sample size, statistical significance was not shown
(P=0.55). Yet, the intervention was brief and acceptable to medically fragile patients. A large
number of patients had the following comorbidities: 57.14% had Type 2 Diabetes, 38.1%
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Myocardial Infarction, 28.57% Heart Failure, 25% pre-existing depression, 85.71%
Hypertension, 90.48% Hyperlipidemia, 33.33% Chronic Obstructive Pulmonary Disease,
23.81% obesity, 19.05% anemia, and 19.05% anxiety. Another 33.33% had current tobacco use
with 19.05% with former tobacco use. The preliminary findings from this project confirm the
prevalence of depression defined in the literature and show upon analysis 60% of those screened
for depressive symptoms who received intervention improved after CBT.
CONCLUSION: Depression screening is important because the prevalence of depression in
patients post CABG in this project were on par with the national average rates of depression
among heart disease patients who have had a CABG. The World Health Organization (WHO) has
estimated that by the year 2020, that both CHD and depression will be the two major causes of
disability-adjusted life years. The recommendation made by American Heart Association (AHA)
to screen all patients with CHD should be established routinely. Depression screening and CBT
are both feasible and do not require many resources. Implementation of depression screening in
acute and outpatient settings may lead to adequate treatment as recommended by the AHA. The
quality of life and lifespan for this cohort of patients may improve in addition to prevention of
adverse health outcomes caused by untreated depressive symptoms including but not limited to
increased mortality and even suicide from untreated depressive symptoms.
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Risk for Depression in Coronary Heart Disease Patients Meriting Post-Coronary
Artery Bypass Graft Screening: Feasibility of Nurse-led Cognitive Behavioral Therapy among
Patients with Depressive Symptoms
Introduction
Coronary Artery Bypass Graft (CABG) surgery is a common treatment for Coronary
Heart Disease (CHD), with more than 400,000 operations in the United States of America
occurring each year (Center for Disease Control, 2015). Due to the high rates of depression
among CABG patients both pre- and post-operatively; the American Heart Association (AHA)
recommends depression screening for all patients with CHD (American Heart Association, 2008
and 2011). According to the AHA, however, nearly half of all providers do not screen for
comorbid depression in patients with CHD, including patients post CABG (AHA, 2008).
In this evidence-based practice project, patients post CABG at an academic medical
center were screened for depressive symptoms with the Patient Health Questionnaire-9 (PHQ-9)
and offered CBT if the depression score was 5 or greater. The overall purpose of this DNP
project was to implement depression screening among patients post CABG and demonstrate the
feasibility of a nurse-led Cognitive Behavioral Therapy (CBT) intervention, in order to
encourage routine screening practices among healthcare staff.
Background
In 2015, an estimated 17 million adults over the age of 18 in the United States had at least
one major depressive episode in the past year. This number represented 6.7% of all U.S. adults
(American Psychiatric Association, 2017). However, rates of depression are much higher in
people with CHD who experience a CABG. Nearly 1 out of 5 patients post CABG meet the
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American Psychiatric Association's Diagnostic and Statistical Manual IV (DSM-IV) criteria for a
major or mild depressive episode during post-surgical recovery (Freedland et al., 2009).
Even with high rates of depression, many patients are not currently screened postoperatively for depression, and sometimes, treatment for pre-existing comorbid depression is not
resumed post-operatively. Depression concurrent with a CABG is a strong predictor of postoperative complications, including a longer physical recovery period and a more difficult
emotional recovery (Freedland et al., 2009). Although a large body of research has demonstrated
that depression has a negative impact on the prognosis of patients post CABG, health care staff at
some locations have delayed putting the evidence into clinical practice by not screening for
and/or treating depression in patients post CABG.
In a 2013 study, Haddad et al. found that co-occurrence of depression in CHD led to
poorer outcomes and raised mortality among 803 patients from the CHD registers in Greater
London and concluded that the easy to administer PHQ-9 was a drastically superior tool in
identifying depression. However, the United States Preventive Services Task Force (USPSTF)
found little evidence that one tool is superior, and recommended that the most practical tool for
the clinical setting should be utilized (Manea, Gilbody, & McMillan, 2015). The PHQ-9 is a brief
depression screening tool able to be administered and completed within minutes with scores
ranging from 0 to 27. The PHQ-9 also provides a severity score that can be used for treatment
options and monitoring (Appendices A and B).
According to the Agency for Health Care Policy and Research (2017), depression is
underdiagnosed and undertreated by primary care and other non-mental health practitioners as
they do not currently screen. Adverse health effects of CHD and comorbid depression can
become insurmountable and lead to poorer outcomes if left unscreened and untreated
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(Baumeister, Hutter, & Bengel, 2011). It is imperative that evidence-based practice to screen for
depression be translated into the clinical setting (Reddy, Dunbar, Morgan, & O'Neil, 2008). A
relatively easy way to screen for depressive symptoms is through the use of the PHQ-9. The
PHQ9 is a 9-item, validated instrument that can screen and measure the level of depression
through identifying the frequency of associated depressive symptoms.
Some health care staff are reluctant to screen patients with CHD for depression because
they feel they cannot offer any therapy for this condition. However, depression may be
successfully treated by psychotherapy such as Cognitive Behavioral Therapy, medication, or a
combination of both (American Psychiatric Association, 2017). CBT is the psychotherapeutic
intervention based on the Cognitive Model of depression. Researchers have found that Cognitive
therapy (CT), referred to often by the generic term Cognitive Behavior Therapy (CBT), has had
efficacy in treating depressive symptoms (Beck, 2005). In 1967, Dr. Aaron T. Beck, a
psychiatrist, developed the Cognitive Behavioral Model of depression. The Cognitive Behavioral
Model explained dysfunctional thinking (Beck, 2005), and offers a way to target that thinking
through semi-structured counseling sessions. According to Freedland et al. (2009) CBT was
effective for treating and relieving mild depressive symptoms.
Identification of depression is important and Cognitive Behavior Therapy may be more
effective relative to usual care (Freedland et al., 2015). Cognitive Behavioral Therapy can benefit
cardiac patients with depressive symptoms. In the Enhancing Recovery in Coronary Heart
Disease Patients (ENRICHD) study, a randomized controlled trial, at least 12 to 16 sessions of
cognitive behavioral therapy over 12 weeks were advocated to achieve remission of moderate to
severe depression (Berkman, 2000). The investigators found statistical significance in a
reduction in depressive symptoms in the intervention group when compared with the control
5
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group, at 6 months (Berkman, 2000). The ENRICHD investigators concluded that CBT should
begin as soon as possible (within 28 days) after a cardiac event (Berkman, 2000). Moreover,
there is a large evidence base supporting the use of CBT, and short treatments can also be
helpful.
Conceptual Framework
CBT is based upon the Cognitive Model, developed by Dr. Beck. In the Cognitive Model,
cognitive perceptions of a situation can influence emotions, behaviors, and physical symptoms
(Beck, 2005). In a stressful situation, a patient may have an inaccurate perception, and their
thoughts may become counterproductive or negative. CBT helps the patient identify their
thoughts, and evaluate how realistic the thoughts are, in an effort to change negative thoughts
and improve mood. The Cognitive Model’s purpose is to changing thinking and behavior, and it
does so through interactions with a counselor that encourage the patient or individual to improve
the utility of their thinking patterns (Beck, 2005).
Interventions aimed at changing dysfunctional thinking can improve the emotional,
behavioral, and somatic symptoms of depression (Dekker et al., 2010). Dekker et al. (2010)
demonstrated that bachelor’s-prepared nurses can offer CBT to hospitalized patients at the
bedside. CBT is consistent with nursing interventions of teaching patients to identify stressors or
distress, strategies to lessen the impact of those stressors, and increase perceived control by the
patient (Dekker, 2010). The primary objective of CBT is to change emotions and behavior by
redirecting undesirable cognitive processes. This redirection may benefit heart disease patients
who have depressive symptoms identified on a validated, reasonably sensitive and specific
screening tool such as the PHQ-9.
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Purpose
This project implemented the AHA Science Advisory 2008 and subsequent 2011
recommendation to routinely screen all patients with CHD for depression including those who
have had a CABG. The objectives of this evidence-based project were to:
a) Implement routine screening for patients with CHD who have had a CABG in the
Cardiovascular Intensive Care Unit.
b) Provide patients who screen positive for depressive symptoms with nurse-led
Cognitive Behavioral Therapy (CBT).
c) Offer follow-up care and referral for patients who continue to screen positive for
depressive symptoms two weeks post CBT intervention.
Depression worsens the prognosis for patients who have experienced a CABG surgery,
leading to a 10-30% increase in the relative risk of mortality (Ski, Munnian, Rolley &
Thompson, 2015). There is an increased risk of mortality and adverse outcomes at stake for
patients post CABG with comorbid depression. According to the Cleveland Clinic (2018) nearly
20 percent of patients who have had a CABG surgery experience major depression. It is
essential that patients receive care under a collaborative model that includes post-operative
medication reconciliation for patients with pre-existing depression, routine depression screening,
and subsequent treatment and/or treatment referral when warranted.
The Cardiovascular Intensive Care Unit (CVICU) at the academic medical center where
this project was conducted does not currently routinely screen patients post CABG for
depression. Researchers have found that nearly 30% to 40% of CABG surgery patients
experience depression and anxiety disorders—a rate significantly higher than community
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samples (Tully & Baker, 2012). Patients post CABG who have co-morbid depression are
required to cease taking all anti-depressants pre-operatively, so they are not on the list of current
medications when the patient arrives at the hospital for surgery. These antidepressant
medications are not consistently reconciled post-operatively, leaving patients at risk for untreated
depressive symptoms related to not resuming their anti-depressant therapy.
The CVICU where this project took place is not alone—current evidence indicates that
nearly 50% of all providers neither screen nor treat patients post CABG for depression (AHA,
2011). An AHA Science Advisory (2011) recommends all heart disease patients be screened for
depression due to the increased risk of mortality due to untreated depression. In a cross-sectional
study of 217 patients post CABG, researchers found that the benefits of screening include
improved quality of life and improved adherence to treatment (Luttik, Jaarsma, Sanderman, &
Fleer, 2011). Researchers have also found that it’s possible to lower levels of depressive
symptoms in patients post CABG via the use of pharmacological and/or non-pharmacological
treatment modalities. Both Cognitive Behavioral Therapy (CBT) and Stress Management (SM)
have been found to reduce depressive symptoms which may improve prognosis for patients
recovering from a CABG (Freedland et al., 2009). Implementing routine screening is an
evidence-based practice that is strongly recommended by the AHA, although they acknowledge
that additional research and evaluation are necessary to validate this finding.
Project Design
This project used a non-experimental pre-test and post-test design to establish routine
depression screening among patients post CABG in the Cardiovascular Intensive Care Unit at a
University Hospital, utilizing the validated PHQ-9. Upon consent, an evidence-based, nonpharmacological CBT intervention was provided for patients who had CHD and CABG surgery
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and scored a 5 or greater on the PHQ-9 indicating presence of depressive symptoms. All patients
who received the intervention had a PHQ-9 score of 5 or greater. Patients post CABG who did
not screen positive for depression did not receive CBT; however, all received usual care.
Methods
Procedures
Data collection activities for this project was implemented after informed consent was
obtained. IRB approval was obtained from the University Hospital, and the principal investigator
was the sole researcher and carried out all recruitment activities, the intervention, and data
collection. Data collection occurred from the end of August 2018 to mid-October. An initial
patient visit lasted anywhere from 15 minutes to 1 hour or more for each patient; this visit
included the consent process, depression screening with the PHQ-9, and the CBT intervention if
the depression screen was positive with a score of 5 or greater. Only, two patients refused to
consent to participate in the project. Nearly all patients were amenable to being screened for
depression and receiving CBT intervention if warranted.
All project variables were entered into Excel, and PHQ-9 scores were entered into
Qualtrics. Applicable project variables were stored on an encrypted computer. All data were deidentified, with a random subject ID assigned by Qualtrics software. Patient confidentiality was
maintained throughout the project.
Evidence-based project participants were at least 18 years of age and were screened day 4
post-operatively or greater. The project participants were male and female with various
ethnicities and backgrounds. In terms of illness history, the patients in the sample had a CABG
and current hospitalization with various disease diagnoses in the past medical history and
physical. The primary diagnosis was Coronary Heart Disease (CHD) or Coronary Artery Disease
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(CAD). The major purpose of this evidence-based project was to establish depression screening
for all patients with CHD including those who have had a CABG. If a patient had a positive
depressive symptom score (positive screening of 5 or greater score on the PHQ-9), the patient
received CBT, then was re-screened with the PHQ-9 at their post CABG visit before cardiac
rehabilitation. If the follow-up depression screen score was positive for depression (PHQ-9 score
5 or greater), the provider was notified and referred that patient for treatment and supportive
services.
The effects of the CBT Intervention were assessed by using the PHQ-9 to re-screen each
patient who was given the 30-minute session at the two week post-surgical clinic visit. This visit
occurred after the patient was discharged from the hospital or entered cardiac rehabilitation.
Patients who missed the follow-up post-surgical clinic visit at two weeks were contacted and rescreened via telephone.
The Patient Health Questionnaire 9 (PHQ-9) screening tool was stored on a password
protected iPad. The screening tool is under current review with the University Hospital
administration to have the PHQ-9 embedded in the Electronic Medical record (EMR) in the adult
patient profile.
Patient records were reviewed throughout the data collection period. All who were
enrolled received the following actions related to their depressive symptom scores: 1) patient,
attending physician, staff nurse, and primary care provider were notified of PHQ-9 scores inperson by principal investigator (Appendices A and B); and 2) patients received the National
Institute of Mental Health pamphlet on depression and heart disease (Appendix C). For those
patients with depressive symptoms at baseline, the patient’s provider was made aware of the
PHQ-9 score at the conclusion of depression PHQ-9 re-screening follow-up or in the event of an
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increase in depressive symptoms greater than 25% from baseline. Furthermore, for safety
reasons, the University Hospital suicide protocol outlined on the University Hospital Intranet
was available. If the patient mentioned suicidal ideation at any time point, the policy would be
followed. No subjects were identified as suicidal in this project.
Independent variables were abstracted and used to identify the population of interest. The
University Hospital provided a list of qualifying patients through the EMR database and a
minimum sample of 25 patients were screened, however, 50 patients were reviewed; 21 were
eligible, and those that screened positive for depression were offered follow-up care offered as
appropriate.
Sample
The patients were identified and selected from a convenience sample by pulling every
eligible record during the enrollment period from IRB approval date until the minimum sample
size was achieved. Patients were re-screened for depression at the University clinic practice site
at the initial post-surgical visit approximately two weeks after being sent home from the hospital
after having a CABG heart surgery. The patient interview was comprised of re-screening with the
PHQ-9 at the follow-up visit. The results of the patient interviews were presented to the
cardiologist for treatment referral to primary care team or psychiatry department if the patient
remained depressed with a positive depression screening PHQ-9 score of 5 or greater after CBT
intervention.
Patients were recruited by asking each patient in the sample if they wanted to consent to
participate in this project. Identification of the subjects was established after accessing their
password protected and encrypted information in their EMR within the database after consent.
Patients were approached in the hospital and at their follow-up visit at the University clinic.
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Patients were initially screened for depression while in the hospital four days post-operative or
later to allow time for general anesthesia to leave systemic circulation. Patients were required to
be alert and oriented with an Eye Motor Verbal profile on the Glasgow Coma Scale with a score
of 15.
Setting
The cardiovascular surgeons also referred to as cardiologist at the University Hospital
were notified if their patients with CHD who just had a CABG were administered CBT after
positive depression screen (PHQ-9 score of 5 or greater). There were a total of five
cardiothoracic surgeons in the CVICU, one of which relocated during the project and one was
promoted. All were agreeable as the patient’s provider to have their patient screened for
depressive symptoms and be offered CBT exhibiting feasibility. Each surgeon endorsed each
patient being re-screened at the follow-up visit prior to or during cardiac rehabilitation if they
were given the CBT intervention demonstrating acceptability. If the patient was unavailable for
the follow-up visit, those patients were re-screened for depressive symptoms via telephone or at
the University Hospital clinic practice site, at the initial post-surgical visit approximately two
weeks after being sent home from the hospital post CABG.
No advertising flyer was submitted for IRB approval. Data were obtained from the
encrypted, password protected EMR database on a computer in the CVICU on all cardiovascular
patients who had CHD and a CABG heart surgery from the IRB approval date until the minimum
sample size was achieved. The patient list was obtained from EMR and screening was done on or
after day 4 post-surgery. Patients were in the hospital on post-op day 4 or after and consented
while in the hospital. Those who did not meet the eligibility criteria to receive depression
screening with the validated PHQ-9 were not consented. Adults who were ineligible to receive
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depression screening with the PHQ-9 and subsequent evidence-based CBT upon screening
positive for depressive symptoms included those who have had a serious or life-threatening
event, and/or were still intubated and/or sedated and unable to provide consent.
Patient confidentiality was preserved by coding each patient with a unique subject number,
and storing the code number key on a password protected computer file on the University
Hospital secured encrypted, password-protected server. Data was collected post CABG and at
two-week follow-up.
The demographic variables were recorded and entered into statistical analysis software
SPSS 23 owned by the PI. CBT continuing education training was completed by the principal
investigator through the Beck Depression Institute, and was offered to patients who screened
positive for depression utilizing the validated PHQ-9 depression screening tool post CABG.
Patients were offered follow-up care via primary care or psychiatric provider referral if they rescreened positive for depression at their two week post-surgical clinic visit. Patients were
contacted via telephone if they missed or were not scheduled for the follow-up clinic
appointment to be re-screened with the PHQ-9 validated depression screening tool.
Description of Intervention
The principal investigator was trained on the Cognitive Behavioral Model through the
Beck Institute (2018). The CBT training course took 6 weeks to complete and consisted of an indepth teaching on the principles, foundations, and tenets of CBT delivery. The principal
investigator had to spend over 40-didactic and 60 clinical hours online in order to have adequate
training in the delivery of CBT with patients with depressive symptoms. The principal
investigator watched over 30 case examples of trained CBT expert delivery of CBT prior to
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bedside delivery as an RN in the CVICU with patients with CHD who have had a CABG.
Patients were engaged in various activities throughout the session (See Figure 1).
Socratic questioning were utilized as an evidence-based technique used in cognitive
therapy (Beck Institute, 2018). This line of questioning helps the patient identify and contest the
legitimacy of thoughts, beliefs and assumptions associated with a client's troubles, and is based
on the dialectic questioning seen by Socrates (Beck, 1967). Patients were given the opportunity
to express their thoughts and feelings and do a CBT training which taught the patient how to ask
Socratic questions. Each patient was given an opportunity to formulate a coping response and
write down the strategy on a sticky note. Each patient was given the National Institute of Health
Pamphlet on Depression and Heart Disease (Appendix C) and equipped with coping tools to
change negative thoughts. The coping skills were there to remind each patient of how to adjust
their thinking and patients were informed that we would speak again in 2 weeks to re-assess their
progress which would be captured through rescreening the patient on the PHQ9.
The session was summarized for the patient and the patient’s feedback was solicited. The
patient was notified that they would be asked the same nine questions on the PHQ-9 to re-screen
them for depressive symptoms post-CBT intervention at their follow-up visit before cardiac
rehabilitation or via telephone within the 2-week time period after the patient was initially
consented.
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Session

Activities

CBT 30-



minute




Session


(in
hospital)






Oriented patient to: purpose of intervention, collaboration between nurse-patient,
number and length of session, role of homework
Discussed link between depression, anxiety, and heart disease
Told real-life stories of patients with heart disease that illustrate the link between
stress, thoughts, feelings, and behaviors
Asked patient to describe a recent stressful event, along with the thoughts,
feelings, and behaviors that occurred in response to the stressor
Taught patient how to ask Socratic questions
Helped patient formulate a coping response and write it on a sticky note
Homework assignment: read about coping and changing negative thoughts, notice
automatic thoughts throughout week
Summarized the session and get feedback from the patient

Figure 1. RN-led Cognitive Behavioral Therapy Session Activities. Diagram from (Dekker,
Tovar, Doering, Bailey, Campbell, Wright, & Moser, 2014). A single cognitive behavior therapy
session improves short-term depressive symptoms in hospitalized patients with heart failure.
American Heart Association
Measures
In order to measure the outcomes of this DNP evidence-based practice project the following
measures were examined for the project (see Table 1):
1) Demographic variables: Demographic variables included gender, age, ethnicity, marital
status, tobacco use and heart disease classification of patients.
2) PHQ-9: The PHQ-9 is a nine-item instrument that measures depressive symptoms with
severity scores. Responses to each question are on a 4 level Likert scale (0-3). A
summary score is computed with a range of 0 to 27. A score of 5 or higher indicates
clinical depression (Manea, Gilbody, & McMillan, 2015).
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The PHQ-9 has been shown to have sensitivity and specificity for patients with CHD of
61 percent and 94 percent respectively for mood disorders in adults. The first two questions of
the PHQ-9 is the (PHQ-2). The PHQ-2 has a sensitivity of 100 percent and specificity of 77
percent in patients with heart disease (Li, Friedman, Conwell, & Fiscella, 2007). The
psychometrics of PHQ-9 include a sensitivity and specificity of 88 percent when the depression
score tool is used and the score is greater than or equal to 10 or more. PHQ-9 scores of 5, 10, 15,
and 20 respectively indicate the level of depressive symptoms as mild, moderate, moderately
severe and severe respectively (See Appendix B) (Kroenke, Spitzer & Williams, 2001). Lichtman
et al. (2008) proposed that Cardiologists should take depression into account in the management
of CHD, regardless of whether or not they treat the depression or if they decide to refer the
patient to a healthcare provider who is qualified in the assessment and treatment of depression,
which often may be the patient’s own primary care provider. The PHQ-9 is inexpensive and
relatively simple to administer and could provide the providers or their staff an uncomplicated
way to screen patients for depressive symptoms.
Data Analysis
The demographics of the sample were described using frequencies with percentages for
nominal and ordinal variables and means with standard deviations for interval/ratio variables.
The scores on the PHQ-9 at pre-test (post CABG) and post-test (post-CBT intervention) were
described using means with standard deviations. A paired sample t-test was used to determine
changes in PHQ-9 scores from pre-test (baseline) to post-test (post-CBT intervention).
Results
A total of 21 patients were screened for depressive symptoms utilizing the PHQ-9. There
was 1 patient death, 1 patient decline, 2 patient refusals to consent and 1 patient lost to follow-
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up. The patient demographic characteristics regarding age, gender, ethnicity, past medical history
including smoking status, and depression score can be seen in Table 2 and 3. The patients ranged
in age from 55 to 80 years of age, with a mean of 68. The mean age in years for those patients
who were given nurse-led CBT intervention was 70.4 years of age. The majority of patients were
Caucasian (95.24%) with 1 African-American (4.76%). Of the 8 patients with depressive
symptoms, 87.5% (8 out of 21) were male with 12.5% (1 out of 8) were female. A documented
history of comorbid depression was found in (9.5%) of all patients and in 25% (N=8) of patients
who screened positive for depression and received the nurse-led CBT intervention. A total of
19.05% (N=21) of all patients had comorbid anxiety and 50% (N=8) of patients who scored
positive for depressive symptoms on the PHQ-9 had pre-existing anxiety.
Comparisons were documented among comorbidities with a total of 57.14% with Type 2
Diabetes, 38.1% Myocardial Infarction, 28.57% Heart Failure, 19.05% Atrial Fibrillation,
33.33% current tobacco use, 19.05% former tobacco use, 85.71% Hypertension, 90.48%
Hyperlipidemia, 33.33% Chronic Obstructive Pulmonary Disease, 23.81% obesity, 19.05%
anemia, 19.05% anxiety with 100% CHD and CABG. Again, due to limited sample size the
distribution of depression among comorbidities did not yield p-values < 0.5.
Upon analysis, the average reduction in depressive symptoms score was 1.2 (SD=1.83,
range= 0-16) in comparison to when the patient was initially being screened. Depression
screening made clinical staff aware of the patient’s current status of depression level with the
scoring tool providing context to mild, moderate, moderately severe, and severe (See Appendix
A). A statistical comparison of patient variables were analyzed among those screened for
depression (N=21). Using paired t-tests, the differences were not clinically significant related to
limited sample size. However, most (60%) had a reduction in depressive symptoms post- nurse-
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led CBT albeit it was not statistically significant. No other statistically significant differences in
depression screening rates were found in any of the other variable groups based on gender,
ethnicity, or past medical history (p>.05). Frequencies are captured in Table 3 and the results
from the t-tests.
Discussion
In this evidence-based practice project, the prevalence of depression was similar to
national averages as established by the Centers for Disease Control with average depression rates
among heart disease patients at 38% (CDC, 2017). A history of depression was noted in only
10% of the entire surveyed group. Comparisons between the comorbidities (COPD, obesity,
hypertension, type 2 diabetes) showed no significant differences in the rate or degree of
depression. The average rates and severity scores reported in this project indicated a PHQ-9
score of 5 or greater with a max score of 16 qualifying most patients as having mild depression.
The PHQ-9 was utilized for its ease of administration and availability to healthcare staff.
Only 8 patients out of 21 (38%) had an initial score of 5 or greater indicating depressive
symptoms with severity based on that score (see Table 1). The effect of CBT is evaluated within
2 weeks which follows the same timeline for rescreening a patient on the PHQ-9. The PHQ-9
specifically asks “over the last two weeks” had a patient had a specific depressive symptom (See
Appendix A). Allowing 2 weeks after the CBT intervention gave time for the patient to assess
their progress with the homework and information learned during the nurse-led CBT intervention
(See Figure 1).
This project showed that nurse-led CBT may be effective for patients who have mild
depressive scores on the PHQ-9 (score of > 0 or > 10). One patient with comorbid depression
did not benefit from the brief CBT intervention, indicating that some patients may require a more
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robust intervention and/or pharmacological management. However, CBT provided some
reduction in depressive symptoms, yielding a 60% reduction of depressive symptoms among
those who were screened, which resulted in a 1.2 point reduction in severity score. CBT was
straight-forward and uncomplicated to deliver to patients with depressive symptoms on the PHQ9. Most patients were receptive to the CBT activities as described in Figure 1. Patients were
frequently relieved to have targeted therapy focusing on providing them with coping skills as
they recovered from their CABG surgery. With only 2 patient refusals, 1 patient decline, and 1
patient lost to follow-up the screening with the PHQ-9 and subsequent CBT intervention if
warranted showed acceptability. Several larger studies did multiple CBT sessions and showed
efficacy with patients who received the intervention over several sessions (Dekker et al., 2010).
It would be feasible to expand the study in order to provide multiple sessions. However, current
evidence in the literature does indicate that brief sessions may be effective.
Depression treatment may vary based on severity level. Treatment with nonpharmacological interventions such as nurse-led CBT may offer improvement in the short-term
in patients with depressive symptoms that are mild. Traditional pharmacological treatment may
include a SSRI medication which has been deemed effective in multiple studies including the
large multicenter, double-blind randomized control trial of 369 depressed patients with heart
disease who were hospitalized known as SADHART “Sertraline treatment of major depression in
patients with Acute Coronary Syndromes” study (Glassman et al., 2002). A collaborative care
model is key to following-up with patients with depressive symptoms and exchanging clinical
information between provider services in an effort to mitigate depressive symptoms; which
increases the mortality rate among patients post CABG by 10-30%. Given the concern of time
constraints as one factor in why providers do not screen their patients for depression, having a
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useful and relatively simple tool as the PHQ-9 available to screen and nurse-led CBT in place
could improve screening and subsequent treatment rates (AHA, 2011).
Limitations
A larger sample size is needed to indicate statistical significance verifying depression
prevalence and correlation with CHD and CABG Heart Surgery. This was a single practice
location with a non-diverse sample and small group numbers. Several limitations existed during
the evidence-based project including the main Heart Surgeon being promoted to Chief of Surgery
which decreased CABG surgeries listed as a result. A longer enrollment period and multi-site
study would potentially lend to a larger sample size and increased depression screening and
identification of subjects with depressive symptoms.
In future studies, care giver role strain evaluation should be coupled with screening of the
patient with PHQ-9. During enrollment and project activities it was noted that the spouse,
significant other or caregiver expressed need for depression screen and subsequent treatment. In
nearly all patients that were screened for depressive symptoms, the caregiver was at the patient
bedside during CBT-intervention, indicating an opportunity to evaluate both cohorts
simultaneously.
Implications for Practice
The resources that are needed to establish a screening protocol for CABG patients pre- and
post-operatively would include training on the use of the validated tools for depression
screening; Patient Health Questionnaire (PHQ) 2 and PHQ-9. Training on nurse-driven
Cognitive Behavioral Therapy (CBT) treatment provided by Beck Depression Institute would
also be necessary but may be time intensive and other opportunities for short competencies
should be evaluated for implementation into practice. Community resources availability would
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need to be evaluated to assist with depression burden. Psychiatric or supportive services would
need to be in place for patient follow-up. Implementing a Psychiatric Advanced Practice
Registered Nurse on the patient care service lines may help alleviate any barriers to follow-up
care or supportive services, giving patients access to psych services which often times is limited.
Also, copies of the PHQ-2 and PHQ-9 to be utilized by patients during screening would need
to be available as a screening tool. Access and use of the electronic medical record at point of
patient encounter if diagnosis of CHD or CAD is present including those patients who have had a
CABG would be included. Expansion to other patients with CHD such as those on Ventricular
Assist Devices as well as Extra Corporeal Membrane Oxygenation will be vital given rates for
depression are even higher in these specialized cardiovascular populations. Providers that will
champion screening patients pre- and post-operatively is needed to have widespread screening
practices established. An embedment into the EMR along with provider alert capability would
ensure scores are captured and appropriate follow-up care would be instituted. The process for
initiation of medication reconciliation for patients with known comorbid depression preoperatively is also important to mitigate the negative effects imposed upon the patient when
comorbid untreated or undertreated depression is present. Interdisciplinary collaboration with
Pharmacy and other disciplines may lend itself to ensuring patients have psychiatric medications
restarted right away and a comprehensive approach to individualized patient care.
Conclusion
In summary, the high prevalence of depression in patients with CHD including those that
have had a CABG heart surgery supports a strategy of routine screening for depression. Routine
screening can be assessed with the PHQ-9 and treatment or referral can subsequently be provided
when merited. Improving routine depression screening implementation among providers in the
critical care setting and post-operatively can be further enhanced by providing an evidence-based
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intervention such as CBT to decrease negative effects that result from comorbid depression in
patients with CHD. Depression exacerbates adverse outcomes in patients with CHD including
those who have had a CABG. Therefore, identifying depression in patients with CHD and those
with a CABG is vital. This project sought to acknowledge depression exacerbates adverse
outcomes in patients post CABG justifying the usefulness of screening all patients with CHD
who have had a CABG and offering Nurse-led CBT which was effective.
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Table 1. Characteristics and Demographics: Post CABG depression screen with PHQ-9 and
Nurse-led CBT (N =21).
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Table 3. Comorbidities: Post-CABG depression screen with PHQ-9 and Nurse-led CBT (N =21).
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